Swiss National Bank
TSHA icon

Swiss National Bank’s Taysha Gene Therapies TSHA Stock Holding History

Swiss National Bank’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2M Hold
268,800
– – ﹤0.01% 2084
2025
Q4 		$1.48M Buy
+268,800
New +$1.31M ﹤0.01% 2002
2022
Q2 		– Sell
-41,000
Closed -$267K – 2792
2022
Q1 		$267K Buy
41,000
+3,500
+9% +$26.2K ﹤0.01% 2665
2021
Q4 		$437K Hold
37,500
– – ﹤0.01% 2685
2021
Q3 		$698K Hold
37,500
– – ﹤0.01% 2521
2021
Q2 		$795K Buy
+37,500
New +$864K ﹤0.01% 2548

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM